Debasish Tripathy

Articles by Debasish Tripathy

TPS 24 Phase Ib Dose-Finding Study of [177Lu]Lu-NeoB + Ribociclib + Fulvestrant in Patients With ER+/HER2− Advanced Breast Cancer With GRPR Expression With Early Relapse FromAdjuvant Endocrine Therapy or Progression on ET + CDK4/6i for ABC

ByDebasish Tripathy,Dejan Juric,Sonia Pernas,Francois Clement Bidard,Kevin Perraud,Louise Emmett,Ana Sofia Ferreira

June 22nd 2025

TPS 25 Phase 1/2 Study of the Novel Radioligand Therapy [177Lu]Lu-NeoB Plus Capecitabine in Patients With ER+/HER2− Advanced Breast Cancer (ABC) With GRPR Expression After Progression on Prior Endocrine Therapy Plus a CDK4/6 Inhibitor for ABC

ByMario Campone,Louise Emmett,Dejan Juric,Debasish Tripathy,Sonia Pernas,Monica Zuradelli,Kevin Perraud,Aleix Prat

June 21st 2025

Latest Updated Articles

Trending on CancerNetwork

Key Takeaways for Multidisciplinary Lung Cancer Care From WCLC 2026

Pembrolizumab/Enfortumab Vedotin Earns Positive CHMP Opinion in MIBC

FDA Approves Imlunestrant Combo in ESR1-Mutated Breast Cancer

NCCN Guidelines Strengthen MRD Testing Recommendations in Multiple Myeloma

CELMoDs After T-Cell–Engaging Therapy in Multiple Myeloma